Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) will look for M&A. Chandan Basho Chief Strategy and Financial Officer said during the Third Quarter 2023 Earnings Call, "we also announced an oversubscribed term loan of $300 million, which increases the company's facility to $700 million with our existing $400 million revolver. We intend to use these funds to position us for future M&A transactions, which allow us to continue to expand our geographic footprint and grow our membership base. Through this process, we were able to negotiate expanded baskets within our overall facility, including increasing the maximum levels of certain forms of permitted indebtedness, increasing the maximum levels of restricted payments, including share repurchases, and increasing the maximum levels of certain investments".